Clinical Trial

Long-term Outcomes of Patients with Rheumatoid Arthritis in Remission

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this multi-center prospective observational study is to develop knowledge on how to best personalize treatment and follow-up strategies for patients with RA in remission, with the intention to prevent relapse of disease activity and progression of joint damage and at the same time avoid the use of unnecessary treatment and health resources. The investigators will perform an extensive evaluation of all patients who participated in the ARCTIC REWIND study 10 and 15 years after they achieved sustained remission and received different treatment strategies.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-01-09; most recent amendment 2025-03-07.
Trial Details
NCT Number NCT06783322
Lead Sponsor Diakonhjemmet Hospital
Collaborators: South-Eastern Norway Regional Health Authority, The Research Council of Norway, Olav Thon Foundation
Conditions Rheumatoid Arthritis (RA)
Enrollment 259 participants
Start Date 2025-11
Primary Completion 2034-01 (estimated)
Study Completion 2034-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-10